Skip to main content
    C

    Crescent Capital BDC Inc (CCAP)

    Official site

    FINANCIAL SERVICES • ASSET MANAGEMENT • NASDAQ

    $9.88
    -0.20 (-1.98%)

    Market Cap: $371.41M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Crescent Capital BDC Inc (CCAP) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Crescent Capital BDC (CCAP) has a market cap of $371.41M and an enterprise value of $1.24B. Its net debt of $873.07M equals 235.07% of its market cap. Revenue grew 21.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 235.07% above the market cap, as debt exceeds cash.

    Market Cap$371.41M
    Enterprise Value$1.24B
    Latest price (Nov 17, 2026)$9.88

    Key Dates

    The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 31, 2026.

    Next Earnings DateFeb 23, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Next Ex-Dividend DateDec 31, 2026
    Next Payment DateJan 15, 2027
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.02% in the quarter ended Sep 30, 2026 and shrank 0.29% a year over 2 years.

    Shares Outstanding36.85M
    Shares Change (YoY)-0.58%
    Shares Change (QoQ)-0.02%
    Share Count Growth (2Y CAGR)-0.29%

    Valuation Ratios

    Sales and book value multiples are 2.9x and 0.6x. Its year-end P/E ranged from 6.6x to 10.5x from 2020 to 2025.

    P/E Ratio6.2x
    Forward P/E6.5x
    P/S Ratio2.9x
    Forward P/S2.5x
    P/B Ratio0.6x
    P/FCF Ratio7.0x
    P/OCF Ratio7.1x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 20.5x EBITDA and 23.8x free cash flow.

    EV / Sales10.0x
    EV / EBITDA20.5x
    EV / FCF23.8x

    Price Statistics

    The stock is down 20.33% over 52 weeks and trades 6.24% above its 50-day average.

    Beta (1Y)0.55
    52-Week Change-20.33%
    1-Month Change+13.56%
    3-Month Change-4.65%
    6-Month Change-5.24%
    5-Year Change-53.86%
    Total Return (1Y)-7.34%
    Total Return (3Y CAGR)-5.85%
    Total Return (5Y CAGR)-1.61%
    Return vs SPY (1Y)-29.91%
    Max Drawdown (1Y)-38.78%
    Max Drawdown (3Y)-48.69%
    Sharpe Ratio (1Y)-0.69
    Correlation with SPY (1Y)0.25
    50-Day Average$9.30
    200-Day Average$10.92
    52-Week Range$8.39 to $13.42
    RSI (14 Days)57.7
    Average Volume (20 Days)200.25K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.54x current liabilities, and total debt is 1.39x shareholder equity.

    Current Ratio1.54x
    Quick Ratio1.54x
    Debt / Equity1.39x
    Debt / EBITDA15.03x
    Debt / FCF17.48x
    Interest Coverage0.77x

    Returns and Efficiency

    Return on invested capital is 1.84% over the last 12 months, against a 5-year average of 12.50%.

    Return on Equity (ROE)-0.02%
    Return on Assets (ROA)-0.01%
    Return on Invested Capital (ROIC)1.84%
    ROE (5Y Average)8.30%
    ROA (5Y Average)3.85%
    ROIC (5Y Average)12.50%
    Asset Turnover0.08x
    Receivables Turnover15.63x

    Scores

    CCAP has an Altman Z-Score of 0.15, in the distress zone below 1.81, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score0.15
    Altman Z ZoneDistress
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $124.18M over the last 12 months.

    Revenue$124.18M
    Revenue Growth (YoY)+21.00%
    Gross Profit$96.54M
    Operating Income$83.40M
    Pretax Income$1.84M
    Net Income-$156.00K
    Reported EPS (TTM)$1.60

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 40.81% of the $1.60B in total assets.

    Cash and Equivalents$36.20M
    Total Debt$909.27M
    Net Debt$873.07M
    Net Debt Per Share$23.70
    Working Capital$15.33M
    Shareholder Equity$652.93M
    Book Value Per Share$17.72
    Total Assets$1.60B
    Total Liabilities$948.51M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $0 of capital spending, operating cash flow left $52.01M of free cash flow.

    Operating Cash Flow$52.01M
    Capital Expenditures$0
    Free Cash Flow$52.01M
    FCF Per Share$1.41
    Depreciation and Amortization$30.24M
    Dividends Paid$76.88M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 67.16%, against a 5-year average of 64.94%.

    Gross Margin77.75%
    Operating Margin67.16%
    Pretax Margin1.48%
    Net Margin-0.13%
    FCF Margin41.88%
    Gross Margin (5Y Average)68.77%
    Operating Margin (5Y Average)64.94%
    Net Margin (5Y Average)52.67%

    Growth

    Revenue grew 44.19% a year over 3 years, and EPS fell 2.84% a year.

    Revenue Growth (3Y CAGR)+44.19%
    Revenue Growth (5Y CAGR)+27.40%
    EPS Growth (3Y CAGR)-2.84%
    EPS Growth (5Y CAGR)-0.34%
    FCF Growth (3Y CAGR)+38.79%
    Operating Income Growth (3Y CAGR)+93.15%
    Book Value Per Share Growth (2Y CAGR)-2.32%
    Tangible Book Per Share Growth (2Y CAGR)-2.31%

    Revenue and profit by year

    Dividends and Yields

    CCAP pays out 75.81% of earnings as dividends.

    Dividend Per Share (Annual)$1.48
    Payout Ratio75.81%
    FCF Payout Ratio147.84%
    Earnings Yield16.13%
    FCF Yield14.29%
    Shareholder Yield21.12%

    Full dividend history

    Peer Position

    Against 12 similar companies, CCAP has the 11th highest P/E.

    P/E Ratio6.2x vs 7.8x median
    P/S Ratio2.9x vs 4.2x median
    ROIC1.84% vs 2.91% median
    Revenue Growth (Trailing 4 Quarters, YoY)+21.00% vs -12.28% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -5.15% and EPS growth at -9.40% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-5.15%
    EPS Growth Forecast (2Y CAGR)-9.40%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CCAP

    What is CCAP's market cap?

    Crescent Capital BDC has a market cap of $371.41M. Its enterprise value, which adds debt and subtracts cash, is $1.24B.

    What is CCAP's P/E ratio?

    Crescent Capital BDC has a trailing P/E ratio of 6.2x and a forward P/E of 6.5x.

    How many shares of CCAP are outstanding?

    Crescent Capital BDC has 36.85M shares outstanding. The count is down 0.58% from a year earlier.

    Does CCAP pay a dividend?

    No. Crescent Capital BDC does not pay a dividend.

    How much debt does CCAP have?

    Crescent Capital BDC has $909.27M of total debt and $36.20M of cash and equivalents, a net debt position of $873.07M.